Neurocrine Biosciences is a pioneer in the biopharmaceutical industry, focused on developing treatments for patients with challenging neurological, neuroendocrine, and neuropsychiatric conditions. By combining rigorous scientific expertise with a deeply compassionate approach, the company is bridging the gap between discovery and patient care.
With a robust portfolio of FDA-approved therapies and a diverse clinical-stage pipeline, Neurocrine is uniquely positioned to address high unmet medical needs. The company prides itself on its 'brave science' culture, which encourages employees to pursue bold solutions and push the boundaries of modern medicine in an inclusive and collaborative environment.